Guillain Barre Syndrome after vaccination against Corona Virus Disease19: Managed in limited resource setting

  • Sher Bahadur Kamar Department of Internal Medicine, Seti Provincial Hospital
  • Uttam Kumar Bhatta Department of Internal Medicine, Seti Provincial Hospital
  • Ratna Singh Intensive Care Unit, Seti Provincial Hospital
  • Manju Paudel Timilsana Medical ward Seti Provincial Hospital
DOI: https://doi.org/10.33314/jnhrc.v20i4.4134

Abstract

A 16-year-old boy who classically featured Guillain Barre Syndrome (GBS) after Corona Virus Disease-19 vaccination was timely treated successfully in limited resource setting in far western province. After Moderna (mRNA COVID 19 Vaccine) vaccination, he rapidly developed ascending paralysis of limbs without autonomic and sensory or cranial nerve involvement. He has been treated with Intravenous Immuno-Globulin (IVIG). Over six-weeks long observation and supportive care and he was discharged with full recovery. Many GBS cases after vaccination have been reported but yet to know the association of vaccine. It is very important to address the complication for successful vaccination programme.
Keywords: Complication; COVID-19; guillain barre syndrome; vaccine

Published
2023-07-20
How to Cite
KamarS. B., BhattaU. K., SinghR., & Paudel TimilsanaM. (2023). Guillain Barre Syndrome after vaccination against Corona Virus Disease19: Managed in limited resource setting. Journal of Nepal Health Research Council, 20(4), 1013-1015. https://doi.org/10.33314/jnhrc.v20i4.4134
Issue
Vol. 20 No. 4 (2022): Issue 57 Oct-Dec, 2022
Section
Case Report

Copyright (c) 2023 Sher Bahadur Kamar, Uttam Kumar Bhatta, Ratna Singh, Manju Paudel Timilsana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Nepal Health Research Council JNHRC allows to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. Copyright is retained by author. The JNHRC work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).